BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28062709)

  • 1. Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R.
    Kang S; Hong J; Lee JM; Moon HE; Jeon B; Choi J; Yoon NA; Paek SH; Roh EJ; Lee CJ; Kang SS
    Mol Cancer Ther; 2017 Jan; 16(1):217-227. PubMed ID: 28062709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival.
    Kang SS; Han KS; Ku BM; Lee YK; Hong J; Shin HY; Almonte AG; Woo DH; Brat DJ; Hwang EM; Yoo SH; Chung CK; Park SH; Paek SH; Roh EJ; Lee SJ; Park JY; Traynelis SF; Lee CJ
    Cancer Res; 2010 Feb; 70(3):1173-83. PubMed ID: 20103623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of T-cell invasion across cultured fibroblast monolayers by phenothiazine-related calmodulin inhibitors: impairment of lymphocyte motility by trifluoperazine and chlorpromazine, and alteration of the monolayer by pimozide.
    Grabski R; Dewit J; De Braekeleer J; Malicka-Blaskiewicz M; De Baetselier P; Verschueren H
    Biochem Pharmacol; 2001 May; 61(10):1313-7. PubMed ID: 11322935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trifluoperazine as an alternative strategy for the inhibition of tumor growth of colorectal cancer.
    Qian K; Sun L; Zhou G; Ge H; Meng Y; Li J; Li X; Fang X
    J Cell Biochem; 2019 Sep; 120(9):15756-15765. PubMed ID: 31081173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
    Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
    Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric effects of the antipsychotic drug trifluoperazine on the energetics of calcium binding by calmodulin.
    Feldkamp MD; O'Donnell SE; Yu L; Shea MA
    Proteins; 2010 Aug; 78(10):2265-82. PubMed ID: 20544963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells.
    Linxweiler M; Schorr S; Schäuble N; Jung M; Linxweiler J; Langer F; Schäfers HJ; Cavalié A; Zimmermann R; Greiner M
    BMC Cancer; 2013 Dec; 13():574. PubMed ID: 24304694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination.
    Zhang X; Xu R; Zhang C; Xu Y; Han M; Huang B; Chen A; Qiu C; Thorsen F; Prestegarden L; Bjerkvig R; Wang J; Li X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):118. PubMed ID: 28870216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repositioning of the antipsychotic trifluoperazine: Synthesis, biological evaluation and in silico study of trifluoperazine analogs as anti-glioblastoma agents.
    Kang S; Lee JM; Jeon B; Elkamhawy A; Paik S; Hong J; Oh SJ; Paek SH; Lee CJ; Hassan AHE; Kang SS; Roh EJ
    Eur J Med Chem; 2018 May; 151():186-198. PubMed ID: 29614416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifluoperazine inhibits spreading and migration of cells in culture.
    Connor CG; Brady RC; Brownstein BL
    J Cell Physiol; 1981 Sep; 108(3):299-307. PubMed ID: 7287823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between IDH1 WT and calmodulin and its implications for glioblastoma cell growth and migration.
    Kang S; Kwon HN; Kang S; Park S
    Biochem Biophys Res Commun; 2020 Mar; 524(1):224-230. PubMed ID: 31983428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inside job: Annexin 1A-Inositol 1,4,5-trisphosphate receptor interaction conveys endoplasmic reticulum luminal Ca
    Wahl AM; Yule DI
    Cell Calcium; 2020 Sep; 90():102250. PubMed ID: 32668368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trifluoperazine on calcium binding by calmodulin. A microcalorimetric study.
    Tanokura M; Yamada K
    J Biol Chem; 1985 Jul; 260(15):8680-2. PubMed ID: 4019446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPC channel interactions with calmodulin and IP3 receptors.
    Zhu MX; Tang J
    Novartis Found Symp; 2004; 258():44-58; discussion 58-62, 98-102, 263-6. PubMed ID: 15104175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study.
    Kuo KL; Liu SH; Lin WC; Hsu FS; Chow PM; Chang YW; Yang SP; Shi CS; Hsu CH; Liao SM; Chang HC; Huang KH
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors.
    Stout MA; Silver PJ
    J Cell Physiol; 1992 Oct; 153(1):169-75. PubMed ID: 1522130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma.
    Bhat K; Saki M; Vlashi E; Cheng F; Duhachek-Muggy S; Alli C; Yu G; Medina P; He L; Damoiseaux R; Pellegrini M; Zemke NR; Nghiemphu PL; Cloughesy TF; Liau LM; Kornblum HI; Pajonk F
    Proc Natl Acad Sci U S A; 2020 May; 117(20):11085-11096. PubMed ID: 32358191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma.
    Yeh CF; Lee WY; Yu TH; Hsu YB; Lan MC; Lan MY
    Head Neck; 2023 Feb; 45(2):316-328. PubMed ID: 36349408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin Binding to Death Receptor 5-mediated Death-Inducing Signaling Complex in Breast Cancer Cells.
    Fancy RM; Kim H; Zhou T; Zinn KR; Buchsbaum DJ; Song Y
    J Cell Biochem; 2017 Aug; 118(8):2285-2294. PubMed ID: 28092099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Bcl-2-IP
    Distelhorst CW
    Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.